BIOMODAL LIMITED
Research and experimental development on biotechnology
BIOMODAL LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Full company profile for BIOMODAL LIMITED (08005377), an active life sciences and medical technology company based in United Kingdom. Incorporated 26 Mar 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2022–2024)
Cash in Bank
£20.00M
Net Assets
£28.41M
Total Liabilities
£3.39M
Turnover
£3.31M
Employees
104
Debt Ratio
11%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
See all 6 funding rounds
Sign up to view complete fundraising history
Investors (8)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Oct 2014 | Series A |
| Investor 2 | Oct 2014 | Series A |
| Investor 3 | Jan 2016 | Series C, Series D, Series B |
See all 8 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Ostadan, Omead | Director | American | United States | 20 Jul 2022 | Active |
See all 22 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
No PSC information available
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
Building 400, Chesterford Park, Little Chesterford, Saffron Walden (CB10 1XL) UTTLESFORD | Leasehold | - | 5 Jun 2017 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 12 May 2026 | Officers | Appointment of Omead Ostadan as director | |
| 12 May 2026 | Confirmation Statement | Confirmation statement made on 26 Mar 2026 with updates | |
| 12 May 2026 | Miscellaneous | Replacement filing of SH01 - 12/03/26 Statement of Capital gbp 2679.5736 | |
| 17 Apr 2026 | Capital | Allotment of shares (GBP 2,679.5736) on 10 Jan 2026 | |
| 17 Apr 2026 | Capital | Allotment of shares (GBP 2,679.5736) on 10 Jan 2026 |
Appointment of Omead Ostadan as director
Confirmation statement made on 26 Mar 2026 with updates
Replacement filing of SH01 - 12/03/26 Statement of Capital gbp 2679.5736
Allotment of shares (GBP 2,679.5736) on 10 Jan 2026
Allotment of shares (GBP 2,679.5736) on 10 Jan 2026
Recent Activity
Latest Activity
Appointment of Omead Ostadan as director
3 weeks ago on 12 May 2026
Confirmation statement made on 26 Mar 2026 with updates
3 weeks ago on 12 May 2026
Replacement filing of SH01 - 12/03/26 Statement of Capital gbp 2679.5736
3 weeks ago on 12 May 2026
Allotment of shares (GBP 2,679.5736) on 10 Jan 2026
1 months ago on 17 Apr 2026
Allotment of shares (GBP 2,679.5736) on 10 Jan 2026
1 months ago on 17 Apr 2026